Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Final draft guidance

Final appraisal document (PDF 243 KB)

Committee papers (PDF 5.43 MB)

Public committee slides (PDF 545 KB)

Final scope (PDF 213 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 259 KB)

Equality impact assessment (Scoping) (PDF 122 KB)

Final stakeholder list (PDF 209 KB)

Draft scope post referral (PDF 373 KB)

Draft matrix post referral (PDF 341 KB)